Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.
Santos JR, Cozzi-Lepri A, Phillips A, De Wit S, Pedersen C, Reiss P, Blaxhult A, Lazzarin A, Sluzhynska M, Orkin C, Duvivier C, Bogner J, Gargalianos-Kakolyris P, Schmid P, Hassoun G, Khromova I, Beniowski M, Hadziosmanovic V, Sedlacek D, Paredes R, Lundgren JD; EuroSIDA study group. Santos JR, et al. HIV Med. 2018 May;19(5):324-338. doi: 10.1111/hiv.12581. Epub 2018 Feb 1. HIV Med. 2018. PMID: 29388732 Free article.
OBJECTIVES: The aim of the study was to evaluate the long-term response to antiretroviral treatment (ART) based on atazanavir/ritonavir (ATZ/r)-, darunavir/ritonavir (DRV/r)-, and lopinavir/ritonavir (LPV/r)-containing regimens. ...CONCLUSIONS: Although confounding by indi …
OBJECTIVES: The aim of the study was to evaluate the long-term response to antiretroviral treatment (ART) based on atazanavir/ritonav …
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.
Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group. Cozzi-Lepri A, et al. HIV Med. 2018 Feb;19(2):102-117. doi: 10.1111/hiv.12557. Epub 2017 Oct 6. HIV Med. 2018. PMID: 28984429 Free PMC article.
OBJECTIVES: There are currently few data on the long-term risk of cancer and death in individuals taking raltegravir (RAL). ...
OBJECTIVES: There are currently few data on the long-term risk of cancer and death in individuals taking raltegravir (RAL). ...
[Immune reconstitution inflammatory syndrome in human immunodeficiency (HIV) infected patients].
Agmon-Levin N, Elbirt D, Sthoeger ZM. Agmon-Levin N, et al. Among authors: sthoeger zm. Harefuah. 2008 May;147(5):439-44, 477, 476. Harefuah. 2008. PMID: 18770968 Review. Hebrew.
In a subset of patients' immune reconstitution, after initiation of therapy, it is associated with a pathological inflammatory response leading to a paradoxical short term morbidity and even mortality, defined as the immune reconstitution inflammatory syndrome (IRIS). ...
In a subset of patients' immune reconstitution, after initiation of therapy, it is associated with a pathological inflammatory response lead …
n-3 fatty acids and the immune system in autoimmunity.
Ergas D, Eilat E, Mendlovic S, Sthoeger ZM. Ergas D, et al. Among authors: sthoeger zm. Isr Med Assoc J. 2002 Jan;4(1):34-8. Isr Med Assoc J. 2002. PMID: 11802309 Free article. Review.
In short-term studies, both in animals and in humans, fish oil seems to exert anti-inflammatory effects. However, these effects may vanish during long-term treatment. There is a possibility that in autoimmune diseases, supplementation of dietary n-3 fatty acids migh …
In short-term studies, both in animals and in humans, fish oil seems to exert anti-inflammatory effects. However, these effects may v …
Systemic lupus erythematosus in 49 Israeli males: a retrospective study.
Sthoeger ZM, Geltner D, Rider A, Bentwich Z. Sthoeger ZM, et al. Clin Exp Rheumatol. 1987 Jul-Sep;5(3):233-40. Clin Exp Rheumatol. 1987. PMID: 3427838
However, more than half of the male patients (53%) had a benign course of disease characterized by long remissions requiring minimal or no medication. Long-term remission of serious renal involvement was observed completely in 14 and partially in 5 out of 33 patients. ...
However, more than half of the male patients (53%) had a benign course of disease characterized by long remissions requiring minimal or no m …